Method for preparing binary acid

Through biological/chemical conversion method, the synergistic effect of carbonyl-α,ω-dibasic acid, monooxygenase and molecular sieve encapsulated catalysts is solved, and the dibasic acid is realized efficient, selective preparation and green environmentally friendly production.

CN118931979APending Publication Date: 2024-11-12BEIJING RISUN TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410985231.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

In the existing process, when preparing dibasic acid, the oxidant has problems such as toxicity, high energy consumption and poor selectivity, and the instability of hydrogen peroxide leads to low utilization, making it difficult to achieve green and sustainable production.

Method used

The dibasic acid was prepared by ester bond hydrolysis using the synergistic action of carbonyl-α,ω-dibasic acid, monooxygenase and molecular sieve encapsulated catalysts, and the target product was selected and efficiently obtained.

Benefits of technology

It realizes efficient and selective preparation of dibasic acid, reduces costs, reduces waste emissions, meets green and environmental protection requirements, avoids catalyst loss, and is simple and safe to operate.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004957209240000021
    Figure BDA0004957209240000021
  • Figure FDA0004957209150000011
    Figure FDA0004957209150000011
  • Figure HDA0004957209300000011
    Figure HDA0004957209300000011
Patent Text Reader

Abstract

The invention discloses a method for preparing binary acid. According to the method, carbonyl-alpha, omega-binary acid is used as a raw material, under the combined action of monooxygenase and a molecular sieve encapsulated catalyst, oxygen is selectively added to one side with more carbon number of carbonyl to obtain ester fatty diacid, the ester fatty diacid is subjected to ester bond hydrolysis under the action of the molecular sieve encapsulated catalyst which is continuously added after being heated, and the ester fatty diacid is subjected to acid hydrolysis under the action of the molecular sieve encapsulated catalyst which is continuously added after being heated. And a selective target product binary acid can be obtained.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biocatalysis, in particular to a method for preparing dibasic acid using carbonyl-α, ω-dibasic acid as raw material, and particularly to a method for preparing dibasic acid using unsaturated fatty acid as substrate through biological / chemical conversion. Background Art

[0002] Organic dibasic acids are important fine chemicals. They can react with monohydric alcohols to obtain corresponding dibasic carboxylic acid esters, which are used as plasticizers and lubricants. They can also be used to manufacture hydraulic fluids, agricultural chemicals, medicines, dyes, heavy metal salt complexing agents, lubricant additives, etc.

[0003] As medium-chain organic dibasic acids, dibasic acids such as azelaic acid have high use value. For example, they can be used in medicine to treat skin hyperpigmentation, pigmentation, melanoma, etc., and are also used in clinical treatment of acne, etc.; they can be used to produce adhesives, solvents, corrosion inhibitors, cosmetics, etc. Using this organic dibasic acid as a raw material, high molecular weight nylon 69, nylon 99, nylon 910, nylon 1010, etc. can also be prepared, which have the advantages of wear resistance, corrosion resistance, and excellent low-temperature performance; synthetic plasticizers such as dioctyl azelate and isobutyl azelate have good heat resistance, cold resistance, low viscosity, high boiling point, low volatility, and high plasticization efficiency; synthetic lubricants such as dioctyl azelate, didecyl azelate, and ditridecyl azelate have high flash points and good viscosity-temperature characteristics.

[0004] Most unsaturated fatty acids in natural oils and fats have an unsaturated double bond at the 9th position, and can be oxidized and cracked to produce dibasic acids. However, the difficulty in production is the main reason why dibasic acids such as azelaic acid are in short supply for a long time. At present, the oxidants used for oxidative cracking of oleic acid to prepare dibasic acids include ozone, oxygen, hydrogen peroxide, nitric acid, organic peroxyacids, potassium persulfate, potassium permanganate, sodium periodate and sodium hypochlorite; among them, the ozone oxidation method was the first to be industrialized, but the oxidant ozone used has certain toxicity and the production process has high energy consumption, and the product yield is low; nitric acid, organic peroxyacids, potassium persulfate, potassium permanganate, sodium periodate and sodium hypochlorite have strong oxidizing properties, but poor selectivity and are not environmentally friendly; hydrogen peroxide oxidation agent is green and pollution-free, but it is unstable during the reaction process and is easy to decompose itself, so its utilization rate is not high and it does not have industrial development value; therefore, developing a new method for oxidative cracking of natural unsaturated fatty acids to prepare organic dibasic acids under mild conditions will greatly reduce costs, reduce the discharge of three wastes, and better meet the needs of green and sustainable production.

[0005] In view of the shortcomings of the existing process and the requirements of green and environmentally friendly bio-based products, the present invention develops a green process route for preparing dibasic acids by combining biological and chemical methods, providing a new idea for the efficient production of dibasic acids. Summary of the invention

[0006] The purpose of the present invention is to provide a method for preparing dibasic acid by biological / chemical transformation using unsaturated fatty acid as substrate. The method of the present invention effectively utilizes enzyme / chemical catalysis technology to provide support for the selective and efficient preparation of dibasic acid.

[0007] In order to achieve the above object, the present invention adopts the following technical solution:

[0008] A method for preparing a dibasic acid, the reaction scheme of which is as follows:

[0009]

[0010] Wherein, m≥n, n+m≥15; preferably, 19≥n+m≥15, m≥n, 9≥n≥7;

[0011] The method for preparing a dibasic acid comprises the following steps:

[0012] (1) Carbonyl-α,ω-dicarboxylic acid is reacted to obtain ester fatty diacid under the catalytic action of monooxygenase and molecular sieve encapsulated catalyst;

[0013] (2) adding a molecular sieve encapsulated catalyst to the reaction system at 150-250° C., and ester fatty diacids are catalyzed by the molecular sieve encapsulated catalyst to obtain a dibasic acid as an ester bond hydrolysis product;

[0014] Wherein, in steps (1) and (2), the molecular sieve encapsulated catalyst is a zeolite molecular sieve in-situ encapsulated heteropoly acid salt catalyst, and the heteropoly acid salt is selected from H4SiW 12 O 40 、H3PW 12 O 40 、H3PMo 12 O 40 One or more of .

[0015] Under the joint action of monooxygenase and molecular sieve encapsulated catalyst, carbonyl-α, ω-dicarboxylic acid is selectively oxygenated on the side with more carbonyl carbons to obtain ester fatty diacid. After heating, the latter will undergo ester bond hydrolysis under the action of the molecular sieve encapsulated catalyst that is continued to be added to obtain the selective target product dicarboxylic acid.

[0016] In a specific embodiment, in step (1), the monooxygenase comprises one or more selected from P450 monooxygenase, flavin monooxygenase and BV monooxygenase, preferably BV monooxygenase.

[0017] In a specific embodiment, in step (1), the usage ratio of carbonyl-α,ω-dicarboxylic acid, monooxygenase, and molecular sieve encapsulated catalyst is 3-7 mmol: 15-30 U: 100-300 mg.

[0018] In a specific embodiment, in step (1), the reaction temperature can be 25-35°C, preferably 30°C; the reaction time can be 6 to 20 hours, preferably 14 hours.

[0019] In a specific embodiment, in step (1), the pH of the reaction may be 6 to 9, preferably 7.

[0020] In a specific embodiment, in step (1), the reaction is carried out in a solvent, and the solvent may be water or a buffer, such as 50 mM citrate / phosphate buffer (pH 6.5).

[0021] In a specific embodiment, in step (2), the catalytic hydrolysis bond cleavage reaction of the molecular sieve encapsulated catalyst is carried out at a high temperature, preferably at 150-160° C.; the reaction time is 2-20 hours, for example 5-10 hours.

[0022] In a specific embodiment, in step (2), the ratio of the amount of the ester fatty diacid to the molecular sieve encapsulated catalyst to be added is 2.5-6.0 mmol: 60-100 mg.

[0023] In a specific embodiment, examples of the dibasic acid obtained in the present invention include: azelaic acid, sebacic acid, undecanedioic acid, and the like.

[0024] In a specific embodiment, the zeolite molecular sieve in-situ encapsulated heteropoly acid salt catalyst is a NaY type zeolite molecular sieve in-situ encapsulated heteropoly acid salt catalyst; the encapsulated heteropoly acid salt is selected from H4SiW 12 O 40 、H3PW 12 O 40 、H3PMo 12 O 40 One or more of, preferably H3PMo 12 O 40 .

[0025] In the present invention, the zeolite molecular sieve in-situ encapsulates the heteropolyacid catalyst, which, on the one hand, plays an oxygen-affinity positioning role in step (1), so that the carbonyl-α, ω-dicarboxylic acid is oxygenated on the side with a larger number of carbonyl carbons under the action of monooxygenase to obtain ester fatty diacid; on the other hand, in the chemical catalysis stage, it catalyzes the hydrolysis of the ester bond of the ester fatty diacid under high temperature conditions, thereby controlling the acquisition of the target product dicarboxylic acid.

[0026] In a specific embodiment, the preparation method of the NaY type zeolite molecular sieve in-situ encapsulated heteropoly acid salt catalyst comprises the following steps:

[0027] S1: Mix the calcined NaY molecular sieve and deionized water in a liquid-solid mass ratio of 5:1 to 15:1, adjust the pH of the slurry to 2.0 to 6.0, and then heat it to 60 to 150°C to react the slurry under reflux stirring for 2 to 6 hours; after the reaction is completed, wait for the slurry to cool, filter the residue, centrifuge the precipitate, wash with deionized water, bake the obtained solid at 80 to 150°C for 8 to 20 hours, and calcine at 400 to 650°C for 5 to 8 hours to obtain a modified NaY molecular sieve;

[0028] S2: Dissolve the modified NaY type molecular sieve and tungstate and / or molybdate in deionized water at a mass ratio of 1:5 to 1:10, and adjust the pH of the slurry to 6.0 to 8.0; react the slurry at 100 to 160°C for 8 to 20 hours, add silicic acid or phosphoric acid to the slurry pH of 1.5 to 3.0 after cooling, heat to 30 to 60°C and reflux for 15 to 20 hours; wash after cooling, dry at 90 to 120°C, and calcine at 200 to 300°C for 2 to 6 hours to obtain the NaY type zeolite molecular sieve in-situ encapsulated heteropolyacid catalyst.

[0029] In step S1, the pH of the slurry is adjusted to 2.0-6.0 using an acid solution 1, wherein the acid solution 1 is an aqueous solution of one or more selected from citric acid, malic acid, and oxalic acid, and the concentration thereof is 0.1-0.5 mol / L.

[0030] In step S2, the pH of the slurry is adjusted to 6.0-8.0 using an acid solution 2, wherein the acid solution 2 is an aqueous solution of one or more selected from nitric acid, sulfuric acid, and hydrochloric acid, and the concentration thereof is 1-3 mol / L. In step S2, the washing is performed by washing with ether and a hydrochloric acid solution (1-4 mol / L) in sequence to remove silicotungstic acid, phosphotungstic acid, and phosphomolybdic acid on the surface.

[0031] In a specific embodiment, the carbonyl-α, ω-dicarboxylic acid can be obtained by the following steps:

[0032] (i) Unsaturated α,ω-dicarboxylic acids are converted into carbonyl-α,ω-dicarboxylic acids under the action of hydratase and dehydrogenase.

[0033] In a specific embodiment, the unsaturated α, ω-diacid structure is COOH(CH2)m-1CH2=CH2(CH2) n COOH or COOH(CH2) m CH2=CH2(CH2) n-1COOH; wherein m≥n, n+m≥15; preferably, 19≥n+m≥15, m≥n, 9≥n≥7. The unsaturated α,ω-dicarboxylic acid undergoes double bond addition under the action of hydratase to obtain hydroxy-α,ω-dicarboxylic acid (COOH(CH2) m CH(OH)CH3(CH2) n COOH), and further dehydrogenating the hydroxyl group to a carbonyl group under the action of a dehydrogenase to obtain the carbonyl-α, ω-dicarboxylic acid.

[0034] In a specific embodiment, the hydratase comprises one or more selected from enolase, epoxide hydratase and double bond hydratase, preferably double bond hydratase.

[0035] In a specific embodiment, the dehydrogenase comprises one or more selected from alcohol dehydrogenase, aldehyde dehydrogenase and acid dehydrogenase, preferably alcohol dehydrogenase, more preferably ethanol dehydrogenase.

[0036] In a specific embodiment, the usage ratio of unsaturated α, ω-dicarboxylic acid to hydratase and dehydrogenase is 5-10 mmol: 1500-3000 U: 1500-3000 U.

[0037] In a specific embodiment, the reaction temperature may be 25-35°C, preferably 30°C; the reaction time may be 10 to 45 hours, preferably 24 hours.

[0038] In a specific embodiment, the pH of the reaction may be 6 to 9, preferably 7;

[0039] In a specific embodiment, the solvent of the reaction can be water, a buffer, such as 50 mM citrate / phosphate buffer (pH 6.5).

[0040] In some embodiments, steps (i) and (1)-(2) can be carried out in a multi-enzyme cascade reaction in the same reaction system, and the reaction conditions are as described above.

[0041] In a further specific embodiment, the unsaturated α,ω-dicarboxylic acid can be obtained by fermenting unsaturated fatty acids as substrates with Candida tropicalis.

[0042] In a specific embodiment, the structure of the unsaturated fatty acid is CH3(CH2) m-1 CH2=CH2(CH2) n COOH, COOH(CH2) m-1 CH2=CH2(CH2) n CH3 or CH3(CH2) m CH2=CH2(CH2)n-1 COOH, COOH(CH2) m CH2=CH2(CH2) n-1 CH3, m, n are defined as above. In a further embodiment, examples of the unsaturated fatty acids include: oleic acid, arachidonic acid, erucic acid, etc. Correspondingly, examples of the unsaturated α,ω-dicarboxylic acids include: cis-9-ene-1,18-octadecandicacid, cis-11-ene-1,20-eicosandicacid, cis-13-ene-1,22-eicosandicacid, etc.

[0043] In a specific embodiment, the process of using unsaturated fatty acids as substrates and fermenting them with Candida tropicalis to obtain unsaturated α,ω-dicarboxylic acids includes:

[0044] a) inoculating tropical Candida seed liquid into a culture medium for the first stage of culture; preferably, the culture medium comprises the following components (g / L): 15-30 glucose, 1-5 peptone, 5-10 yeast extract, 5-10 yeast nitrogen base, and 5-12 potassium dihydrogen phosphate; the culture conditions are: temperature of 25-35° C., ventilation of 1.0-2.0 vvm, dissolved oxygen controlled to be not less than 60%, preferably not less than 80%, and culture time of 10-20 h;

[0045] b) adding unsaturated fatty acids to the culture medium to continue fermentation, controlling the pH value of the fermentation system to below 8.0, and the dissolved oxygen to above 50%, to convert the long-chain unsaturated fatty acids into unsaturated α, ω-diacids; preferably, the fermentation time is 60 to 160 hours.

[0046] In a further specific embodiment, in step a), the inoculation amount of the Candida tropicalis seed solution is 10% to 30% of the fermentation starting volume.

[0047] The method for preparing the tropical Candida seed liquid comprises the following steps:

[0048] 1) inoculating tropical Candida into a liquid culture medium for pre-culture; preferably, the liquid culture medium comprises the following components: 5-15 g / L yeast extract; 10-30 g / L peptone; 15-30 g / L glucose; the pre-culture conditions are: shaking at 200-300 rpm, 25-35° C. for 18-25 hours;

[0049] 2) inoculating the bacterial solution obtained by pre-culture in step 1) into a culture medium for transformation culture to obtain a seed solution; preferably, the culture medium comprises the following components: glucose, 15-30 g / L; peptone, 1-5 g / L; yeast extract, 5-10 g / L; yeast nitrogen base, 5-10 g / L; potassium dihydrogen phosphate 5-12 g / L; the culture conditions are: shaking at 200-300 rpm, 25-35° C. for 18-25 hours.

[0050] Compared with the prior art, the method of the present invention has the following beneficial effects:

[0051] (1) The present invention uses carbonyl-α,ω-dicarboxylic acid as a raw material, and under the joint action of monooxygenase and molecular sieve encapsulated catalyst, selectively oxygenates the side with a larger number of carbonyl carbons to obtain ester fatty diacids, and the latter undergoes ester bond hydrolysis under the action of the molecular sieve encapsulated catalyst that is continuously added after heating, thereby obtaining a selective target product dicarboxylic acid.

[0052] (2) The present invention uses unsaturated fatty acids as raw materials and prepares dibasic acids through biological and chemical methods in a coordinated manner, and there is no problem of catalyst loss, which is expected to form a strong competition with the fatty acid cracking method.

[0053] (3) The reaction process of preparing dibasic acid by biological method of unsaturated fatty acid of the present invention does not involve acid or alkali, and the reaction operation is simple and safe.

[0054] (4) The present invention develops and preliminarily verifies the technology of microbial conversion of unsaturated fatty acids, which reduces the unit consumption of product raw materials, simplifies the separation process, and has obvious advantages in reaction economy. BRIEF DESCRIPTION OF THE DRAWINGS

[0055] Figure 1 The reaction pathway diagram for preparing azelaic acid from oleic acid via biological / chemical conversion in Examples 2 to 4 is schematically shown.

[0056] Figure 2 The time course of conversion of cis-9-ene-1,18-octadecandicarboxylic acid into azelaic acid in Examples 3 to 4 is schematically shown. DETAILED DESCRIPTION

[0057] The terms used herein are only used for the purpose of describing exemplary embodiments and are not intended to limit the present invention. Unless the context clearly indicates otherwise, the singular form also includes the plural form. It should be understood that when used in this specification, the terms "comprising", "consisting of" or "having" specify the presence of the features, integers, steps, components or combinations thereof, but do not exclude the presence or addition of one or more other features, integers, steps, components or combinations thereof.

[0058] The technical solution of the present invention is further described below in conjunction with several embodiments.

[0059] Unless otherwise specified, the raw materials, reagents, methods, equipment, etc. used in this application are conventional raw materials, reagents, methods, and equipment in the art.

[0060] Reagents and sources

[0061] NaY molecular sieve was purchased from Sinopec Catalyst Aoda Branch;

[0062] Sodium tungstate, sodium silicate nonahydrate, and sodium molybdate were purchased from Sinopharm Chemical Reagent Co., Ltd.;

[0063] Candida tropicalis was purchased from Ningbo Mingzhou Biotechnology Co., Ltd. with product number BMZ126131.

[0064] Peptone, yeast extract, double bond hydratase, alcohol dehydrogenase, and BV monooxygenase were purchased from Sigma with catalog numbers P6838, 79883, HPA022476, A3263, and ZRB1609, respectively.

[0065] Fatty acids, dibasic acids, ethanol, hexane, and ethyl acetate were purchased from Sinopharm Group Co., Ltd.

[0066] Glucose, glycerol, sodium chloride, methanol and buffer solution were purchased from J&K Technology Co., Ltd.

[0067] The products in the following examples were detected by analyzing the TMS derivatives of fatty acids by gas chromatography-mass spectrometry (GC-MS) (Agilent, Santa Clara, CA, USA). (Ethyl acetate containing 0.5 g / L palmitic acid methyl ester was used as the internal standard for the bioconversion products of oleic acid, arachidonic acid, and erucic acid. The organic phase was harvested after the reaction on a vortex oscillator and then derivatized with TMS). The gas chromatography-mass spectrometry (GC-MS) was equipped with a flame ionization detector and a split injection system (split ratio was set to 1:10) and equipped with an SPB-1 capillary column (15 m × 0.32 mm inner diameter, 0.25 μm thickness) (Supelco, Bellfonte, PA, USA). The column temperature was increased from 90°C to 255°C at a rate of 5°C / min and then maintained at 255°C. The temperatures of the injector and detector were 260°C and 250°C, respectively.

[0068] The concentration of diacids during biotransformation was measured by high performance liquid chromatography (HPLC) using the purified product as a standard. High performance liquid chromatography analysis and quantification (Shimadazu LC-20A HPLC) was performed on a C18 reverse phase column with dimensions of 150 × 4.6 mm and a particle size of 5 μm. The mobile phase composition was: 10% H2O, 5% acetonitrile, 5% formic acid solution (≥98%, AR) and 80% methanol, v / v.

[0069] The products in the following examples were isolated by solvent extraction and concentrated by evaporation. The dicarboxylic acid product was purified from the reaction medium by recrystallization from ethyl acetate-hexane.

[0070] Example 1 Preparation of Molecular Sieve Encapsulated Catalyst

[0071] (1) Weigh a certain amount (5-20g) of calcined NaY molecular sieve, add deionized water according to the liquid-solid mass ratio of 10:1, mix and slurry; slowly add 0.4mol / L citric acid solution under stirring, adjust the pH value of the slurry to 3.5, then heat to 90℃, and react the slurry under reflux stirring for 4h. After the reaction, wait for the slurry to cool, filter out the residue, centrifuge to get the precipitate, wash with deionized water, then put the sample into an oven and bake at 90℃ for 14h, take it out and put it into a muffle furnace and calcine it at 550℃ for 6h to obtain the modified NaY molecular sieve for use.

[0072] (2) Weigh the modified NaY molecular sieve and a certain amount of tungstate and dissolve them in deionized water (molecular sieve mass: salt mass = 1:6), slowly add nitric acid (2 mol / L) until the pH of the slurry is 7.5, stir for a period of time, add the slurry to the reactor and react at 130°C for 16 hours, cool and add phosphoric acid (3 mol / L) until the pH is 2, heat to 50°C and stir under reflux for 18 hours, add ether (about 1 / 3 of the volume of the mixture) and 3 mol / L hydrochloric acid solution after the slurry is cooled to room temperature for ultrasonic treatment. Filter the residue, centrifuge to get the precipitate, wash with deionized water, wash the heteroacid (phosphotungstic acid) on the surface of the obtained sample, dry overnight at 90-120°C, and calcine at 200-300°C for 2-6 hours to obtain the NaY zeolite molecular sieve in-situ encapsulated heteropolyacid catalyst.

[0073] Example 2 Preparation of cis-9-ene-1,18-octadecane dicarboxylic acid by fermentation using oleic acid as substrate

[0074] (1) Preparation of fermentation seed solution:

[0075] The glycerol tube strain of Candida tropicalis was inoculated into 30 mL of liquid culture medium (in g / L, yeast extract, 10; peptone, 20; glucose, 20) for pre-culture. The pre-culture conditions were shaking at 250 rpm and 30°C for 20 hours in a 500 mL flask.

[0076] The bacterial liquid obtained from the pre-culture was inoculated at 10% (v / v) into 30 mL of culture medium (in g / L, the culture medium contained peptone, 3; yeast extract, 6; yeast nitrogen base, 6.7; potassium dihydrogen phosphate, 9.3; glucose, 20) for cultivation to obtain tropical Candida tropicalis seed liquid. The culture conditions were shaking at 250 rpm and 30°C for 20 hours in a 500 mL flask.

[0077] (2) Fermentation

[0078] In a 30L fermentation tank filled with 15L culture medium, 1.5L tropical Candida seed solution was added to start fermentation. The culture medium components of the fermentation tank include (g / L): glucose, 20; peptone, 3; yeast extract, 6; yeast nitrogen base, 6.7; potassium dihydrogen phosphate 9.3. The culture conditions are: growth at 30°C, 900rpm, ventilation of 1.5vvm, and control of dissolved oxygen not less than 80%.

[0079] After 12 hours of fermentation, the bioconversion phase was started by feeding 2 mL / L of oleic acid. Glucose (500 g / L) as a co-substrate was continuously fed at a rate of 1.2 g / L / h. During the bioconversion phase, the pH was automatically maintained at 7.6 by adding NaOH solution, and the dissolved oxygen was controlled at about 60%. In order to avoid excessive foaming, defoamer 204 was added as needed. Every 12 hours, 5 ml aliquots were taken from the fermentation medium to determine cell growth, glucose concentration, fatty acid consumption and diacid production.

[0080] The total culture time from inoculation to the end of fermentation was 140 hours, the molar conversion rate of oleic acid was 80%, and the selectivity of the product cis-9-ene-1,18-octadecandicarboxylic acid was 85%.

[0081] Product characterization: The molecular weight of the obtained product determined by GC / MS was 312, which was consistent with the calculated result of cis-9-ene-1,18-octadecandicacid.

[0082] Example 3 Preparation of ester fatty diacids using cis-9-ene-1,18-octadecane dicarboxylic acid as raw material

[0083] Reaction route Figure 1 The time course of the conversion of unsaturated dibasic acid into target dibasic acid is shown in Figure 2 , specifically including the following steps:

[0084] (1) The cis-9-ene-1,18-octadecane dicarboxylic acid (~6 mmol) obtained in Example 2 was added to a 50 mM citrate / phosphate buffer solution (100 mL) containing a double bond hydratase (10 g / L), the pH of the solution was maintained at about 7, the reaction temperature was 30°C (the same temperature was maintained in steps (2) and (3)), and the reaction was carried out for 5 hours to obtain 9-hydroxyoctadecane dicarboxylic acid; product characterization: the molecular weight of the obtained product determined by GC / MS was 330, which was consistent with the calculated result of 9-hydroxyoctadecane dicarboxylic acid.

[0085] (2) adding alcohol dehydrogenase (20 U / mL) to the above reaction solution and reacting for 5 hours to obtain 9-carbonyl octadecane dicarboxylic acid; product characterization: the molecular weight of the obtained product determined by GC / MS is 328, which is consistent with the calculated result of 9-carbonyl octadecane dicarboxylic acid.

[0086] (3) BV monooxygenase (20 U / mL) and the molecular sieve encapsulated catalyst (140 mg) prepared in Example 1 were added to the above mixed solution and reacted on a vortex oscillator for 14 h to catalytically convert 9-ester octadecane dicarboxylic acid to a final concentration of about 45.2 mM.

[0087] Product characterization: The molecular weight of the obtained product determined by GC / MS is 344, which is consistent with the calculated result of 9-ester octadecane dicarboxylic acid. Combined with the subsequent analysis and detection results of dicarboxylic acids, it is shown that fatty dicarboxylic acids with a certain oxygenation position are obtained.

[0088] Example 4 Preparation of Azelaic Acid Using 9-Ester Octadecanedioic Acid as Raw Material

[0089] The buffer solution of 9-ester octadecane dicarboxylic acid obtained in Example 3 was heated to 150° C., and the molecular sieve encapsulated catalyst (100 mg) prepared in Example 1 was added. After reacting for 8 hours, the total content of azelaic acid was measured by GC / MS to be approximately 32.5 mM.

[0090] Product characterization: The molecular weight of the obtained product determined by GC / MS is 188, which is consistent with the calculated result of azelaic acid. The peak position of the obtained product determined by HPLC is consistent with the peak position of azelaic acid.

[0091] The analysis results show that the conversion rate of 9-ester octadecane dicarboxylic acid exceeds 80%, and the selectivity of azelaic acid reaches about 90%.

[0092] Comparative Example 1

[0093] (1) The cis-9-ene-1,18-octadecane dicarboxylic acid (~6 mmol) obtained in Example 2 was added to a 50 mM citrate / phosphate buffer solution (100 mL) containing a double bond hydratase (10 g / L), the pH of the solution was maintained at about 7, the reaction temperature was 30°C (the same temperature was maintained in steps (2) and (3)), and the reaction was carried out for 5 hours to obtain 9-hydroxyoctadecane dicarboxylic acid.

[0094] (2) Alcohol dehydrogenase (20 U / mL) was added to the above reaction solution and reacted for 5 hours to obtain 9-carbonyl octadecane dibasic acid.

[0095] (3) Add BV monooxygenase (20 U / mL) to the above mixture and react on a vortex shaker for 14 h to catalyze the conversion to obtain ester fatty diacids.

[0096] (4) The reaction solution was heated to 150° C., and the molecular sieve encapsulated catalyst (100 mg) prepared in Example 1 was added and reacted for 8 hours. GC / MS and HPLC were used to measure that the product contained a variety of dibasic acids, including suberic acid, azelaic acid, and sebacic acid.

[0097] This indicates that if the molecular sieve encapsulated catalyst is not added in step (3), the ester fatty diacid with a defined oxygenation position cannot be obtained, and thus a single product cannot be obtained.

[0098] Comparative Example 2

[0099] (1) The cis-9-ene-1,18-octadecane dicarboxylic acid (~60 mM) obtained in Example 2 was added to a 50 mM citrate / phosphate buffer solution (100 mL) containing a double bond hydratase (10 g / L), the pH of the solution was maintained at about 7, the reaction temperature was 30°C (the same temperature was maintained in steps (2) and (3)), and the reaction was carried out for 5 hours to obtain 9-hydroxyoctadecane dicarboxylic acid.

[0100] (2) Alcohol dehydrogenase (20 U / mL) was added to the above reaction solution and reacted for 5 hours to obtain 9-carbonyl octadecane dibasic acid.

[0101] (3) Add BV monooxygenase (20 U / mL) to the above mixture and react on a vortex shaker for 14 h to catalyze the conversion to obtain ester fatty diacids.

[0102] (4) The reaction solution was heated to 150° C. and the reaction was continued for 8 hours. No dibasic acid was detected by GC / MS.

[0103] This indicates that without adding the molecular sieve encapsulated catalyst, not only can the ester fatty diacid with a determined oxygenation position not be obtained, but also the ester fatty diacid cannot be oxidized by bond breaking.

[0104] Example 5 Preparation of cis-11-ene-1,20-eicosadicarboxylic acid by fermentation using arachidonic acid as substrate

[0105] According to the method of Example 2, the oleic acid substrate was replaced with arachidonic acid. The total culture time from inoculation to the end of fermentation was 130 hours, the molar conversion rate of arachidonic acid was 76%, and the selectivity of cis-11-ene-1,20-eicosaldicarboxylic acid product was 80%.

[0106] Product characterization: The molecular weight of the obtained product determined by GC / MS was 340, which was consistent with the calculated result of cis-11-ene-1,20-eicosanedioic acid.

[0107] Example 6 Preparation of ester fatty diacid using cis-11-ene-1,20-eicosaldicarboxylic acid as raw material

[0108] (1) The cis-11-ene-1,20-eicosandioic acid (~6 mmol) obtained in Example 5 was added to a 50 mM citrate / phosphate buffer solution (100 mL) containing a double bond hydratase (10 g / L), the pH of the solution was maintained at about 7, the reaction temperature was 30°C (steps (2) and (3) were maintained at the same temperature), and the reaction was carried out for 5 hours to obtain 11-hydroxyeicosandioic acid; product characterization: the molecular weight of the obtained product determined by GC / MS was 358, which was consistent with the calculated result of 11-hydroxyeicosandioic acid.

[0109] (2) adding alcohol dehydrogenase (20 U / mL) to the above reaction solution and reacting for 5 hours to obtain 11-carbonyleicosandedioic acid; product characterization: the molecular weight of the obtained product determined by GC / MS is 356, which is consistent with the calculated result of 11-carbonyleicosandedioic acid.

[0110] (3) Add BV monooxygenase (20 U / mL) and the molecular sieve encapsulated catalyst (180 mg) prepared in Example 1 to the above mixed solution and react on a vortex oscillator for 14 h to obtain 11-ester eicosane dicarboxylic acid. The final concentration of 11-ester eicosane dicarboxylic acid is about 38.6 mM. Product characterization: The molecular weight of the obtained product determined by GC / MS is 372, which is consistent with the calculated result of 11-ester eicosane dicarboxylic acid.

[0111] Example 7 Preparation of Sebacic Acid Using 11-Ester Eicosanedioic Acid as Raw Material

[0112] The buffer solution of 11-ester eicosanedioic acid obtained in Example 6 was heated to 150° C., and the molecular sieve encapsulated catalyst (60 mg) prepared in Example 1 was added. After reacting for 8 hours, the total content of sebacic acid was measured by GC / MS to be about 23.7 mM.

[0113] Product characterization: The molecular weight of the obtained product determined by GC / MS is 202, which is consistent with the calculated result of sebacic acid. The peak position of the obtained product determined by HPLC is consistent with the peak position of sebacic acid.

[0114] The analysis results show that the conversion rate of 11-ester eicosanedioic acid exceeds 72%, and the selectivity of sebacic acid is about 85%.

[0115] Example 8 Preparation of cis-13-ene-1,22-docosadicarboxylic acid by fermentation using erucic acid as substrate

[0116] According to the method of Example 2, the oleic acid substrate was replaced by erucic acid. The total culture time from inoculation to the end of fermentation was 150 hours, the molar conversion rate of erucic acid was 70%, and the selectivity of cis-13-ene-1,22-docosadicarboxylic acid product was about 72%.

[0117] Product characterization: The molecular weight of the obtained product determined by GC / MS was 368, which was consistent with the calculated result of cis-13-ene-1,22-docosadicarboxylic acid.

[0118] Example 9 Preparation of ester fatty diacid using cis-13-ene-1,22-docosahexanedioic acid as raw material

[0119] (1) The cis-13-ene-1,22-docosanedioic acid (~6 mmol) obtained in Example 8 was added to a 50 mM citrate / phosphate buffer solution (100 mL) containing a double bond hydratase (10 g / L), the pH of the solution was maintained at about 7, the reaction temperature was 30° C. (the same temperature was maintained in steps (2) and (3)), and the reaction was carried out for 5 hours to obtain 13-hydroxydocosanedioic acid; product characterization: the molecular weight of the obtained product determined by GC / MS was 386, which was consistent with the calculated result of 13-hydroxydocosanedioic acid.

[0120] (2) adding alcohol dehydrogenase (20 U / mL) to the above reaction solution and reacting for 5 hours to obtain 13-carbonyldocosane dicarboxylic acid; product characterization: the molecular weight of the obtained product determined by GC / MS is 384, which is consistent with the calculated result of 13-carbonyldocosane dicarboxylic acid.

[0121] (3) BV monooxygenase (20 U / mL) and the molecular sieve encapsulated catalyst (180 mg) prepared in Example 1 were added to the above mixed solution and reacted on a vortex oscillator for 14 h to catalytically convert 13-ester docosane dicarboxylic acid. The final concentration of 13-ester docosane dicarboxylic acid was 32.2 mM.

[0122] Product characterization: The molecular weight of the obtained product determined by GC / MS was 400, which was consistent with the calculated result of 13-ester docosane dicarboxylic acid.

[0123] Example 10 Preparation of Undecanedioic Acid Using 13-Ester Docosane Dicarboxylic Acid as Raw Material

[0124] The buffer solution of 13-ester docosane dicarboxylic acid obtained in Example 9 was heated to 150° C., and the molecular sieve encapsulated catalyst (80 mg) prepared in Example 1 was added. After reacting for 8 hours, the total content of undecanedioic acid was measured by GC / MS to be 16.7 mM.

[0125] Product characterization: The molecular weight of the obtained product determined by GC / MS is 216, which is consistent with the calculated result of undecanedioic acid. The peak position of the obtained product determined by HPLC is consistent with the peak position of undecanedioic acid.

[0126] The analysis results show that the conversion rate of 13-ester docosane dicarboxylic acid exceeds 67%, and the selectivity of undecanedioic acid is about 78%.

[0127] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.

Claims

1. A method for preparing a dibasic acid, the reaction scheme of which is as follows: in, m≥n, n+m≥15; The method for preparing a dibasic acid comprises the following steps: (1) Carbonyl-α,ω-dicarboxylic acid is reacted to obtain ester fatty diacid under the catalytic action of monooxygenase and molecular sieve encapsulated catalyst; (2) adding a molecular sieve encapsulated catalyst to the reaction system at 150-250° C., and ester fatty diacids are catalyzed by the molecular sieve encapsulated catalyst to obtain a dibasic acid as an ester bond hydrolysis product; Wherein, in steps (1) and (2), the molecular sieve encapsulated catalyst is a zeolite molecular sieve in-situ encapsulated heteropoly acid salt catalyst, and the heteropoly acid salt is selected from H4SiW 12 O 40 、H3PW 12 O 40 、H3PMo 12 O 40 One or more of .

2. The method for preparing a dibasic acid according to claim 1, characterized in that: In the reaction formula, 19≥n+m≥15, m≥n, 9≥n≥7.

3. The method for preparing a dibasic acid according to claim 1, characterized in that: In step (1): The monooxygenase comprises one or more selected from P450 monooxygenase, flavin monooxygenase and BV monooxygenase, preferably BV monooxygenase; and / or The usage ratio of the carbonyl-α, ω-dicarboxylic acid, the monooxygenase, and the molecular sieve encapsulated catalyst is 3-7 mmol: 1500-3000 U: 100-300 mg; and / or The reaction temperature is 25-35°C and the reaction time is 6 to 20 hours; and / or The pH of the reaction is 6 to 9, preferably 7; and / or The reaction was carried out in a solvent which was either water or 50 mM citrate / phosphate buffer.

4. The method for preparing a dibasic acid according to claim 1, characterized in that: In step (2): The catalytic hydrolysis and bond breaking reaction of the molecular sieve encapsulated catalyst is carried out at 150-160° C.; the reaction time is 2-20 hours, preferably 5-10 hours; and / or The ratio of the ester fatty diacid to the molecular sieve encapsulated catalyst added continuously is 2.5-6 mmol: 60-100 mg; and / or The dibasic acid includes: azelaic acid, sebacic acid, and undecanedioic acid.

5. The method for preparing a dibasic acid according to claim 1, characterized in that: The zeolite molecular sieve in-situ encapsulated heteropoly acid salt catalyst is a NaY type zeolite molecular sieve in-situ encapsulated heteropoly acid salt catalyst; The encapsulated heteropoly acid salt is selected from H4SiW 12 O 40 、H3PW 12 O 40 、H3PMo 12 O 40 One or more of, preferably H3PMo 12 O 40 ; Preferably, the preparation method of the NaY type zeolite molecular sieve in-situ encapsulated heteropolyacid salt catalyst comprises the following steps: S1: Mix the calcined NaY molecular sieve and deionized water in a liquid-solid mass ratio of 5:1 to 15:1, adjust the pH of the slurry to 2.0 to 6.0, and then heat it to 60 to 150°C to react the slurry under reflux stirring for 2 to 6 hours; after the reaction is completed, wait for the slurry to cool, filter the residue, centrifuge the precipitate, wash with deionized water, bake the obtained solid at 80 to 150°C for 8 to 20 hours, and calcine at 400 to 650°C for 5 to 8 hours to obtain a modified NaY molecular sieve; S2: Dissolve the modified NaY type molecular sieve and tungstate and / or molybdate in deionized water at a mass ratio of 1:5 to 1:10, and adjust the pH of the slurry to 6.0 to 8.0; react the slurry at 100 to 160°C for 8 to 20 hours, add silicic acid or phosphoric acid to the slurry pH of 1.5 to 3.0 after cooling, heat to 30 to 60°C and reflux for 15 to 20 hours; wash after cooling, dry at 90 to 120°C, and calcine at 200 to 300°C for 2 to 6 hours to obtain the NaY type zeolite molecular sieve in-situ encapsulated heteropolyacid catalyst.

6. The method for preparing a dibasic acid according to claim 5, characterized in that: In step S1, the pH of the slurry is adjusted to 2.0-6.0 using an acid solution 1, wherein the acid solution 1 is an aqueous solution of one or more selected from citric acid, malic acid, and oxalic acid, and the concentration thereof is 0.1-0.5 mol / L; and / or In step S2, the pH of the slurry is adjusted to 6.0-8.0 using an acid solution 2, wherein the acid solution 2 is an aqueous solution of one or more selected from nitric acid, sulfuric acid, and hydrochloric acid, and the concentration thereof is 1-3 mol / L; and / or In step S2, the washing is performed by sequentially washing with ether and a hydrochloric acid solution (1-4 mol / L).

7. The method for preparing a dibasic acid according to claim 1, characterized in that: The carbonyl-α, ω-dicarboxylic acid is obtained by the following steps: (i) Unsaturated α, ω-dicarboxylic acid is converted into carbonyl-α, ω-dicarboxylic acid under the action of hydratase and dehydrogenase; Preferably, the unsaturated α, ω-diacid structure is COOH(CH2)m-1CH2=CH2(CH2)nCOOH or COOH(CH2) m CH2=CH2(CH2) n-1 COOH; wherein m≥n, n+m≥15; preferably, 19≥n+m≥15, m≥n, 9≥n≥7; and / or The hydratase comprises one or more selected from enolase, epoxide hydratase and double bond hydratase, preferably double bond hydratase; and / or The dehydrogenase comprises one or more selected from alcohol dehydrogenase, aldehyde dehydrogenase and acid dehydrogenase, preferably alcohol dehydrogenase, more preferably ethanol dehydrogenase; and / or The dosage ratio of unsaturated α,ω-dicarboxylic acid to hydratase and dehydrogenase is 5-10mmol:1500-3000U:1500-3000U; and / or The reaction temperature is 25-35°C and the reaction time is 10-45 hours; and / or The pH of the reaction is 6 to 9, preferably 7; and / or The solvent for the reaction was water or 50 mM citrate / phosphate buffer.

8. The method for preparing a dibasic acid according to claim 1, characterized in that: The unsaturated α,ω-dicarboxylic acid is obtained by fermenting unsaturated fatty acids as substrates with Candida tropicalis; Preferably, the structure of the unsaturated fatty acid is CH3(CH2) m-1 CH2=CH2(CH2) n COOH, COOH(CH2) m-1 CH2=CH2(CH2) n CH3, CH3(CH2) m CH2=CH2(CH2) n-1 COOH or COOH(CH2) m CH2=CH2(CH2) n-1 CH3, wherein m≥n, n+m≥15; preferably, 19≥n+m≥15, m≥n, 9≥n≥7; More preferably, the unsaturated fatty acids include: oleic acid, arachidic acid, and erucic acid.

9. The method for preparing a dibasic acid according to claim 8, characterized in that: The process of obtaining unsaturated α,ω-dicarboxylic acid by fermentation of unsaturated fatty acids with Candida tropicalis includes: a) inoculating tropical Candida seed liquid into a culture medium for the first stage of culture; preferably, the culture medium comprises the following components (g / L): 15-30 glucose, 1-5 peptone, 5-10 yeast extract, 5-10 yeast nitrogen base, and 5-12 potassium dihydrogen phosphate; the culture conditions are: temperature of 25-35° C., ventilation of 1.0-2.0 vvm, dissolved oxygen controlled to be not less than 60%, preferably not less than 80%, and culture time of 10-20 h; b) adding unsaturated fatty acids to the culture medium to continue fermentation, controlling the pH value of the fermentation system to below 8.0, and the dissolved oxygen to above 50%, to convert the long-chain unsaturated fatty acids into unsaturated α, ω-diacids; preferably, the fermentation time is 60 to 160 hours.

10. The method for preparing a dibasic acid according to claim 9, characterized in that: In step a), the inoculation amount of the Candida tropicalis seed solution is 10% to 30% of the initial fermentation volume; and / or The method for preparing the tropical Candida seed liquid comprises the following steps: 1) Inoculating tropical Candida into a liquid culture medium for pre-culture; preferably, the liquid culture medium comprises the following components: 5-15 g / L yeast extract; 10-30 g / L peptone; 15-30 g / L glucose; the pre-culture conditions are: Shake at 200-300 rpm, 25-35°C for 18-25 hours; 2) inoculating the bacterial solution obtained by pre-culture in step 1) into a culture medium for transformation culture to obtain a seed solution; preferably, the culture medium comprises the following components: glucose, 15-30 g / L; peptone, 1-5 g / L; yeast extract, 5-10 g / L; Yeast nitrogen base, 5-10 g / L; potassium dihydrogen phosphate 5-12 g / L; culture conditions: shaking at 200-300 rpm, 25-35°C for 18-25 hours.